← HEALTHCARE SERVICES GROUP INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | $77.4m | $88.2m | $83.5m | $64.6m | $98.7m | $45.9m | $34.6m | $38.4m | $39.5m | $59.1m | |
| Depreciation, Depletion and Amortization | $7.5m | $8.9m | $9.3m | $13.9m | $14.3m | $14.7m | $15.3m | $14.3m | $14.6m | $16.8m | |
| Depreciation | $4.8m | $5.0m | $4.9m | $9.7m | $10.1m | $10.3m | $10.5m | $10.5m | $11.9m | $13.0m | |
| Amortization of Intangible Assets | $2.7m | $3.9m | $4.4m | $4.2m | $4.2m | $4.4m | $4.9m | $3.8m | $2.7m | $3.7m | |
| Deferred Income Tax Expense (Benefit) | $3.0m | $1.9m | ($13.0m) | ($684k) | ($5.9m) | $3.1m | $5.0m | ($4.8m) | ($2.9m) | $19.1m | |
| Share-based Payment Arrangement, Noncash Expense | $4.3m | $276k | $5.9m | $6.9m | $7.9m | $8.8m | $9.2m | $9.0m | $9.2m | $12.0m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | $284k | — | — | — | — | — | — | $1.7m | |
| Share-based Payment Arrangement, Expense | $4.3m | $6.0m | $5.9m | $6.9m | $7.9m | $8.8m | $9.2m | $9.0m | $9.2m | $12.0m | |
| Goodwill and Intangible Asset Impairment | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | |
| Gain (Loss) on Disposition of Assets | — | — | — | $0 | ($1.3m) | ($1.5m) | ($1.1m) | ($818k) | ($654k) | ($422k) | |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | — | $0 | $0 | ($532k) | ($2.4m) | |
| Income Tax Expense (Benefit) | $43.0m | $44.7m | $16.4m | $20.5m | $30.5m | $16.0m | $10.5m | $14.7m | $13.5m | $8.8m | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Inventories | $1.5m | $1.9m | ($950k) | ($4.8m) | ($4.9m) | ($5.6m) | ($4.9m) | ($2.7m) | ($1.7m) | $48k | |
| Proceeds from Stock Options Exercised | $6.0m | $12.8m | $8.8m | $3.6m | $2.9m | $2.4m | $410k | $0 | $0 | — | |
| Debt and Equity Securities, Unrealized Gain (Loss) | — | — | ($1.4m) | — | — | — | — | — | — | — | |
| Debt Securities, Available-for-sale, Realized Gain (Loss) | — | — | ($200k) | — | — | — | — | — | — | — | |
| Goodwill | $44.4m | $51.1m | $51.1m | $51.1m | $51.1m | $74.8m | $75.5m | $75.5m | $75.5m | $79.8m | |
| Marketable Securities, Unrealized Gain (Loss) | ($900k) | $1.1m | ($800k) | $2.8m | $2.6m | $1.6m | ($7.5m) | $1.6m | ($500k) | $1.9m | |
| Financing Receivable, Credit Loss, Expense (Reversal) | — | — | — | — | — | — | ($663k) | $6.5m | $6.7m | $14.6m | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | $2.0b | — | — | — | — | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | $41.4m | $7.6m | $80.0m | $93.6m | $217.2m | $37.1m | ($8.2m) | $43.5m | $30.8m | $145.0m | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $5.4m | $5.4m | $4.9m | $4.4m | $4.3m | $5.7m | $5.2m | $5.4m | $6.3m | $5.8m | |
| Net Cash Provided by (Used in) Investing Activities | ($6.5m) | ($15.0m) | ($9.6m) | ($16.5m) | ($36.8m) | ($23.0m) | $2.6m | ($3.3m) | $6.0m | ($11.0m) | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Common Stock | $109k | $95k | $89k | $90k | $93k | $92k | $106k | $0 | $0 | — | |
| Payments for Repurchase of Common Stock | — | $0 | $284k | $587k | — | $21.5m | $0 | $11.3m | $5.0m | $61.6m | |
| Payments of Ordinary Dividends, Common Stock | $53.3m | $55.2m | $57.2m | $59.0m | $60.7m | $62.2m | $63.4m | $0 | $0 | $1.7m | |
| Net Cash Provided by (Used in) Financing Activities | ($44.3m) | ($7.0m) | ($54.0m) | ($75.8m) | ($68.4m) | ($82.7m) | ($38.9m) | ($12.2m) | ($31.0m) | ($63.3m) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | ($14.3m) | $16.5m | $1.3m | $112.0m | ($68.5m) | ($44.5m) | $28.1m | $5.8m | $70.6m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | ($14.3m) | $26.0m | $27.3m | $139.3m | $70.8m | $26.3m | $54.3m | $60.1m | $130.8m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | $1.4m | $3.1m | $3.5m | $1.4m | $1.4m | $2.8m | $7.8m | $6.5m | $1.7m | |
| Income Taxes Paid, Net | $32.5m | $35.4m | $37.7m | $20.0m | $44.9m | $21.2m | $3.3m | $5.6m | $15.2m | $20.4m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.